XiaoMi-AI文件搜索系统
World File Search SystemTaisho
日本绿色投资公司（JICN）
◆ financial institution (57 Institutions) • Government/Group Financial Institutions: Development Bank of Japan Inc., Shinkin Central Bank, The Norinchukin Bank • Mega bank: Mizuho Bank, Ltd., Sumitomo Mitsui Banking Corporation, MUFG Bank, Ltd. • Trust bank: Sumitomo Mitsui Trust Bank, Limited • Regional bank: The Hokkaido Bank, Ltd., North Pacific Bank，Ltd。，Aomori Michinoku Bank，Ltd。，Iwate，Iwate，Ltd. Towa Bank，Ltd。 Higashi-Nippon Bank，Limited，Yokohama，Ltd。，Hachijuni Bank，Ltd。，Nagano Bank，Ltd。，Yamanashi Chuo Bank，Ltd.，Daishi Hokuetsu Bank，Ltd. Hokuriku银行有限公司，Shiga Bank，Ltd。，Kiyo Bank，kiyo Bank，Chugoku Bank Ltd.，Tokushima Taisho Bank，Ltd. Ltd.，Saga Ltd.，Oita Bank，Ltd。，Miyazaki Bank，Ltd。，Miyazaki Taiyo Bank，Ltd.，Higo Bank，Ltd，Ltd，Kagoshima Bank，Ltd。•证券公司：Nomura Holdings，Inc.。•证券公司：Nomura Holdings，Inc.。
在先晚期实体TUM>的患者中，TAK-102（tak-102）的第一阶段1剂量升级试验的更新结果
披露十个：重生及甚至顾问/顾问；布里斯托尔Mys Squire Japan，Chugai Pharma，Daichi Sankyo/UCB日本，Nobelphrma，Ono Pharmaceutical，Parexel，Parexel，Pfizer和Taiho Pharmaceutical的Honoraria；以及Abbvie，Chugai Pharma，Eli Lilly Japan，KBBM，Ortuka，Taiho Pharmaceutical，Tasho Pharmaceutical Holdings，Takeda和Zymeworks的研究资金。yku：Abbvie，Amgen，Boehringer Ingelheim，Incyte，Jansen Oncology和Takeda的顾问/顾问；来自Amgen，Chugai Pharma和Incistence的旅行/住宿/费用；来自伊利礼来日本的Honoraria，Taiho Pharmaceutical和Takeda；以及Abbvie，Amgen，Astellas Pharma，Astrazeneca，Boehringer Ingelheim，Carna Biosciences，Carna Biosciences，Chugai Pharma，Daichi Sankyo/UCB日本，Eli Lilly，Genmab，Genmab，Genmab，Glaxosmithkline，Invinste，Jansen encoltical erongrii erongrii erongriuiu， Ono Pharmaceutical，Taiho Pharmaceutical和Takeda。SK：来自Chugai Pharma，Eisai和Sanfi的Honoraria； Chugai Pharma和Eisai的发言人FE；和的研究资金SK：来自Chugai Pharma，Eisai和Sanfi的Honoraria； Chugai Pharma和Eisai的发言人FE；和